Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
BMC Infect Dis ; 23(1): 899, 2023 Dec 21.
Artigo em Inglês | MEDLINE | ID: mdl-38129788

RESUMO

BACKGROUND: Klebsiella pneumoniae is a pathogen that often infects patients in clinical practice. Due to its high virulent and drug resistance, infected patients are difficult to treat. In clinical practice, Klebsiella pneumoniae can infect patients' intestines, intestines, blood, etc., causing pathological changes. However, there is relatively little information on the impact of Klebsiella pneumoniae on intestinal inflammation and microbial populations. Zebrafish is an excellent biomedical model that has been successfully applied to the virulence assessment of Klebsiella pneumoniae. METHODS: In this study, three clinically isolated representative strains of Klebsiella pneumoniae (high virulence non-resistant, high virulence resistant, and low virulence resistant) were used to infect zebrafish, and their effects on intestinal colonization, inflammation, pathology, and microbial diversity were tested. RESULTS: Enzyme-linked immunoassay (ELISA) showed that Klebsiella pneumoniae significantly increased levels of the cytokines interleukin-1α (Il-1α), interleukin-1ß (Il-1ß), and tumor necrosis factor-α (Tnf-α), which increased inflammatory symptoms. Hematoxylin eosin staining(H&S) showed that Klebsiella pneumoniae treatment caused intestinal lesions in zebrafish, in which KP1053 exposure significantly decreased the number of goblet cells, KP1195 caused epithelial dissolution and exfoliation. In addition, Klebsiella pneumoniae disturbed the composition of intestinal microbiota, and the Shannon index increased, which increased the number of harmful bacteria. CONCLUSIONS: Klebsiella pneumoniae infection can lead to intestinal colonization, inflammation, pathological changes, and changes in microbial biodiversity. This study provides a reference for the intestinal pathology of clinical Klebsiella pneumoniae infection.


Assuntos
Infecções por Klebsiella , Klebsiella pneumoniae , Animais , Adulto , Humanos , Virulência , Peixe-Zebra , Inflamação , Intestinos/microbiologia , Infecções por Klebsiella/microbiologia , Antibacterianos , Testes de Sensibilidade Microbiana
2.
Biotechnol Appl Biochem ; 69(5): 2091-2101, 2022 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-34664729

RESUMO

By studying the expression in patients and cell modeling in vitro, antimicrobial peptides for Klebsiella were screened. Killing curve and membrane permeability experiments are used to study the antibacterial effect of antimicrobial peptides in vitro. Cytotoxicity-related indicators including lipopolysaccharide (LPS), capsule polysaccharide (CPS), and outer membrane protein expression were measured. Intranasal inoculation of pneumoconiosis was used to construct a mouse infection model, and the survival rate and cytokine expression level were tested. Human neutrophil peptide 1 (HNP-1) showed a significant antibacterial effect, which improved the permeability of the outer membrane of K. pneumoniae. Moreover, HNP-1 decreased LPS, CPS content, and outer membrane proteins. K. pneumoniae infection decreased antimicrobial peptide, oxidative stress, and autophagy-related genes, while HNP-1 increased these genes. After coculture with macrophages, the endocytosis of macrophages is enhanced and the bacterial load is greater in the K. pneumoniae + peptide group. Besides, higher levels of pp38 and pp65 in the K. pneumoniae + peptide group. HNP-1 rescued the cytotoxicity induced by K. pneumoniae. The survival rate is significantly improved after K. pneumoniae is treated by HNP-1. All cytokines in the peptide group were significantly higher. HNP-1 promotes immune sterilization by reducing the virulence of multidrug-resistant K. pneumoniae and increasing the ability of macrophages.


Assuntos
Klebsiella pneumoniae , Lipopolissacarídeos , Animais , Humanos , Camundongos , Antibacterianos/metabolismo , Klebsiella pneumoniae/metabolismo , Macrófagos , Esterilização , Virulência , Peptídeos
3.
New Dir Child Adolesc Dev ; 2019(163): 137-162, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30615262

RESUMO

English language readers rarely get glimpses of the state of autism research in China. Given the seriousness of autism, the population of China, and the potential for theoretically interesting cross-cultural insights, we provide a broad survey of research carried out in China on childhood autism. Four themes are considered: etiology, diagnosis, treatment, and education. Autism spectrum disorders (ASD) appears to be a product of epigenetic interactions between genetic and environmental factors; recent Chinese research on etiology reflects this. Current diagnostic procedures in China involve clinical screening and examinations, while research proceeds on brain-imaging techniques for diagnosis. Research on treatment has introduced a comprehensive and moderately effective approach that includes education and training, psychotherapy, and pharmacotherapy. In the realm of education, however, many problems remain, requiring joint efforts of the government and of other societal actors. Finally, there are opportunities for indigenous Chinese concepts and innovations to contribute to the study of ASD.


Assuntos
Transtorno do Espectro Autista , Conhecimentos, Atitudes e Prática em Saúde , Transtorno do Espectro Autista/diagnóstico , Transtorno do Espectro Autista/etiologia , Transtorno do Espectro Autista/psicologia , Transtorno do Espectro Autista/terapia , Criança , China , Educação , Feminino , Interação Gene-Ambiente , Humanos , Masculino , Fatores de Risco , Instituições Acadêmicas , Fatores Sexuais
4.
Infect Drug Resist ; 17: 2591-2605, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38953095

RESUMO

Introduction: The emergence of multidrug-resistant Klebsiella pneumoniae (K. pneumoniae) and the decline of effective antibiotics lead to the urgent need for new antibacterial agents. The aim of this study is to investigate the therapeutic effect of antimicrobial peptides against gentamicin-resistant (RT) K. pneumoniae and to screen effective antimicrobial peptides. Methods: In this study, the RT strains were induced by gradient gentamicin, and the RT strains were selected by detecting the expression levels of efflux pump genes, porin genes, and biofilm formation genes of the strains combined with their effects on the cells. Then the effects of four antimicrobial peptides on the efflux pump activity, biofilm formation level and cell condition after infection were detected to explore the effects of antimicrobial peptides on RT strains. Finally, the RT strain was used to induce a mouse model of pneumonia, and the four antimicrobial peptides were used to treat pneumonia mice for in vivo experiments. The pathological changes in lung tissues in each group were detected to explore the antimicrobial peptide with the most significant effect on the RT strain in vivo. Results: The results showed that the minimal inhibitory concentrations of the RT strains (strain C and strain I) were significantly higher than those of the wild-type strain, and the expression of efflux pump, porin and biofilm formation genes was significantly increased. The antimicrobial peptides could effectively inhibit the biofilm formation and efflux pump protein function of the RT strains. In addition, the antimicrobial peptides showed promising antibacterial effects both in vitro and in vivo. Discussion: Our study provided a theoretical basis for the treatment of gentamicin resistant K. pneumoniae infection with antimicrobial peptides, and found that KLA was significantly superior to LL37, Magainin I, KLA and Dermaseptin (10 µg/mL in cells, 50 µg in mice).

5.
J Coll Physicians Surg Pak ; 29(6): 545-548, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31133154

RESUMO

OBJECTIVE: To investigate the role of PetCO2 monitoring in non-invasive positive pressure ventilation (NPPV) treatment for chronic obstructive pulmonary disease (COPD) patients combined with severe respiratory failure. STUDY DESIGN: A clinical retrospective study. PLACE AND DURATION OF STUDY: The ICU Emergency Department, Wuxi Second People's Hospital, Wuxi, China, from February 2015 to February 2016. METHODOLOGY: A total of 60 COPD patients with respiratory failure were selected. All patients received non-invasive positive pressure ventilation and conventional treatment. PetCO2 values were recorded two hours before and after NPPV treatment. At the same time, blood was collected for arterial blood gas analysis. Changes in PetCO2, PaCO2 and the difference between PaCO2 and PetCO2 (Pa-etCO2) were also monitored to determine the correlation between PetCO2 and PaCO2. RESULTS: After two hours of initial NPPV treatment, among the 60 patients, the PaCO2 and Pa-etCO2 of 40 patients were significantly decreased (66.7%), the PaCO2 and Pa-etCO2 of 20 patients were not significantly decreased (33.3%). The correlation analysis revealed that PaCO2 and PetCO2 were negatively correlated (correlation coefficient r = -0.537, p=0.001, p<0.001). Furthermore, there were no significant correlations between PaCO2 and PetCO2 in the ineffective group (correlation coefficient r = -0.253, p=0.116, p>0.05). CONCLUSION: PaCO2 monitoring could not be replaced by PetCO2 monitoring for patients with COPD combined with severe respiratory failure. Nevertheless, dynamic monitoring can instantly feedback the respiration state, which can guide the respiration, and improve the success rate of NPPV treatment and prognosis.


Assuntos
Dióxido de Carbono/sangue , Ventilação não Invasiva/métodos , Respiração com Pressão Positiva/métodos , Doença Pulmonar Obstrutiva Crônica/sangue , Doença Pulmonar Obstrutiva Crônica/terapia , Insuficiência Respiratória/terapia , Gasometria/métodos , China , Feminino , Humanos , Unidades de Terapia Intensiva , Masculino , Pessoa de Meia-Idade , Pressão Parcial , Insuficiência Respiratória/complicações , Estudos Retrospectivos , Volume de Ventilação Pulmonar/fisiologia , Resultado do Tratamento
6.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue ; 20(8): 482-5, 2008 Aug.
Artigo em Zh | MEDLINE | ID: mdl-18687177

RESUMO

OBJECTIVE: To observe the changes in blood glucose, serum insulin level and insulin resistance of critically ill patients during the acute stage and explore the relationship between the changes and their prognosis. METHODS: Fifty-four patients in intensive care unit (ICU) were enrolled. All the patients were assessed with acute physiology and chronic health evaluation II (APACHE II) scores in 24 hours after admission. Fasting blood glucose (FBG) and fasting insulin (FINS) were determined within 24 hours or the next morning, and then insulin resistance was evaluated by insulin sensitivity index (ISI). According to the APACHE II scores, the severity and prognosis, the patients were stratified into groups respectively. The difference in APACHE II scores, FBG, FINS and ISI among groups were analyzed. Furthermore, the correlation between APACHE II score and FBG, FINS, ISI were studied respectively. RESULTS: Based on APACHE II scores, the patients were divided into group A (APACHE II scoresor=21). The levels of FBG and FINS were found to be elevated with the increase in APACHE II score, and in contrast ISI greatly reduced (P<0.05 or P<0.01). APACHE II scores, FBG and FINS in multiple organ dysfunctions group were significantly higher than in single organ dysfunction group, and ISI was found to be significantly decreased (P<0.05 or P<0.01). Additionally, APACHE II scores and FBG in non-survivor group were obviously higher than those in survivor group, while ISI was markedly lower (all P<0.01), but no difference in FINS levels was found between the two groups. In the 54 critically ill patients, correlation study showed that significant positive correlation was found between FBG and APACHE II score (r=0.816 5, P<0.01, regression equation : y=0.573x+3.072) and significant negative correlation between ISI and APACHE II score (r=-0.703 9, P<0.01, regression equation : y=-0.107x-3.598), but no linear correlation was found between APACHE II score and FINS (r=0.283 0, P>0.05). CONCLUSION: The study suggests that FBG and ISI could be used to evaluate the severity and prognosis. Hyperinsulinemia is found in some critically ill patients, but FINS is not helpful for assessing the severity and outcome.


Assuntos
Resistência à Insulina , APACHE , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Glicemia/metabolismo , Criança , Estado Terminal , Feminino , Humanos , Insulina/sangue , Unidades de Terapia Intensiva , Masculino , Pessoa de Meia-Idade , Prognóstico , Análise de Regressão , Adulto Jovem
7.
Naunyn Schmiedebergs Arch Pharmacol ; 390(6): 651-660, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28349183

RESUMO

Excessive alcohol consumption provides risk to cardiomyopathy with unknown mechanisms. Resveratrol, a plant polyphenol, is widely reported for its cardiovascular benefits, while its effect on alcohol-induced impairments in cardiomyocytes largely remains unknown. Effects of resveratrol on the cardiomyocytes under ethanol insult were studied in vitro. Ethanol exposure in mouse neonatal cardiomyocytes increased cell death and induced a specific loss of tight junction protein, connexin 43. In spite of adverse effects at higher concentrations, resveratrol at 10 µM improved cell viability of cardiomyocytes in the presence of a deleterious dose of ethanol. Importantly, the co-treatment of resveratrol with ethanol exhibited the restoration of connexin 43 protein. Further assays showed that these effects were likely associated with the antioxidative actions of resveratrol, and correlated with the alleviation of MAP kinase activation in cultured cardiomyocytes in response to ethanol. Our data suggests a novel mechanism of cardiomyocyte cell loss under ethanol exposure and provides new evidence of protective effects of resveratrol in the cardiomyocytes.


Assuntos
Conexina 43/metabolismo , Etanol/toxicidade , Miócitos Cardíacos/efeitos dos fármacos , Estilbenos/farmacologia , Animais , Animais Recém-Nascidos , Antioxidantes/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Camundongos , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Miócitos Cardíacos/patologia , Resveratrol
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA